相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
James S. Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical
Arnaldo Lopes y Colombo et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals
Arnaldo L. Colombo et al.
MEDICAL MYCOLOGY (2013)
Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil
Maria Luiza Moretti et al.
MEDICAL MYCOLOGY (2013)
Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey
Marcio Nucci et al.
PLOS ONE (2013)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Accurate Identification of Candida parapsilosis (Sensu Lato) by Use of Mitochondrial DNA and Real-Time PCR
Ana Carolina R. Souza et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy
Sofia Costa-de-Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance
Alicia J. Zimbeck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Breakthrough Invasive Candidiasis in Patients on Micafungin
Christopher D. Pfeiffer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Twelve years of fluconazole in clinical practice:: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
MA Pfaller et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
分享论文
